Hi Beatrice,
Thank you for sharing your side effects. I specifically input your situation into my AI search engine and hope some of the information can be helpful. Verify with your doctor.
Info:
Muscle weakness and leg heaviness are known challenges when navigating low-grade serous ovarian cancer (LGSOC) treatments, particularly when combining a PARP inhibitor like Olaparib (Lynparza) with a MEK inhibitor like selumetinib.
While this specific clinical trial combination targets LGSOC directly, both medications independently carry side effect profiles that can contribute significantly to physical fatigue, muscle pain, and lower-extremity weakness.
You are not alone in navigating these symptoms. Patients on similar regimens frequently report that the toxicities can manifest as a heavy, weighted feeling in the legs or general mobility issues.
Starting oncology physical therapy (PT) is an excellent and highly effective proactive step. Oncology PT is uniquely tailored to cancer patients, focusing on:
• Targeted strengthening to safely combat drug-induced muscle weakness.
• Energy conservation techniques to help manage systemic fatigue.
• Balance and gait training to address any underlying nerve changes or heaviness affecting how you walk.
Critical Steps for Your Clinical Trial
Because you are on an active clinical trial, managing side effects requires strict coordination with your research team. Please ensure you take the following steps:
1. Report to Your Trial Coordinator: Document the exact onset, severity, and timing of your leg weakness and heaviness. Clinical trials have precise protocols for managing side effects, which can include supportive medications, scheduled dose reductions, or temporary treatment holidays to allow your body to recover.
2. Rule out Secondary Causes: Muscle weakness can occasionally stem from underlying, treatable issues common during cancer treatment, such as severe anemia, electrolyte imbalances, or peripheral neuropathy. Your oncology team can run routine blood work to check for these factors.
3. Coordinate PT Goals: Ensure your oncology physical therapist is in direct communication with your trial team so your exercise intensity aligns safely with your current lab values and treatment cycle.
Sharing experiences with others on the exact same trial can provide immense comfort.
Platforms like the Outcomes4Me LGSOC Community and the Ovacome Forum on HealthUnlocked are highly active spaces where patients discuss managing walking difficulties, fatigue, and dose adjustments while on Olaparib combinations.
Beatrice, I sure hope this helps you. Please let us know what your team prescribes.
Hugs, Kaye🥰
It's great that you've already started oncology PT — that's a really proactive step! Muscle weakness and leg heaviness can be side effects experienced during treatment trials, and it's important to keep your oncologist informed about what you're feeling.
Olaparib is a PARP inhibitor used in ovarian cancer treatment Show Full Answer